• Skip to main content
Scientific Sessions
Scientific Sessions Conference Coverage logo
  • Program
  • #ScientificSessions26
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Journeys
Resources
  • Program
  • #ScientificSessions26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Oct 23rd, 2024

TCT at AHA

As part of an educational collaboration between Scientific Sessions and the Cardiovascular Research Foundation’s TCT Conference, #AHA24 is featuring TCT at AHA programming to advance research in CVD and interventional therapies.


23 Aha Zb0487

TCT.01 | Complex Coronary Revascularization: Case-Based Discussion*
Saturday, Nov. 16 | 1:30–2:45 p.m. | Heart Theater II,
Science and Technology Hall
Interventional Treatments

TCT.02 | What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update
From TCT/ESC/AHA*
Saturday, Nov. 16 | 3:15–4:30 p.m. | Heart Theater II,
Science and Technology Hall
Interventional Treatments

TCT.03 | Complex TAVR and Beyond: A Case-Based Discussion*
Sunday, Nov. 17 | 9:45–11:00 a.m. | Heart Theater II,
Science and Technology Hall
Interventional Treatments

TCT.04 | Novel Mitral and Tricuspid Valve Therapies: Current Status and a Glimpse Into the Future*
Sunday, Nov. 17 | 3:30–4:30 p.m. | Heart Theater II,
Science and Technology Hall
Interventional Treatments

TCT.05 | Challenging Decisions in ACS Management: A Case-Based Discussion*
Monday, Nov. 18 | 9:45–11:00 a.m. | Heart Theater II,
Science and Technology Hall
Interventional Treatments


*Not a CE accredited session.

Interesting Stories
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Sponsored by Novartis Pharmaceuticals Corporation
What's New in LDL-C Management for ASCVD and Hypercholesterolemia?
Prompt referral can be lifesaving
Sponsored by Edwards Lifesciences
Prompt referral can be lifesaving
More Content
241116 American Heart Association Keynote 0080
AHA24
Advances in lipid therapeutics
Nov 20th, 2024
Crowd shot
AHA24
New approaches to managing AFib
Nov 20th, 2024
Stage shot
AHA24
Medical therapy for heart failure
Nov 20th, 2024
Stage shot
AHA24
Innovation in prevention
Nov 20th, 2024
Asgar headshot
AHA24
Managing patients with symptomatic mitral or tricuspid regurgitation
Nov 18th, 2024
Shot of speakers
AHA24
Environmental crises call for more CV research
Nov 18th, 2024
Aha24 Nejm Web Image
AHA24
Streamlining the pathway to publish cardiovascular research
Nov 18th, 2024
Casadei headshot
AHA24
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Nov 18th, 2024
Stage shot
AHA24
Coronary and valvular heart disease
Nov 18th, 2024
Headshots of speakers
AHA24
Improving patient outcomes for sudden cardiac arrest
Nov 18th, 2024
audience shot
AHA24
Redefining arrhythmia treatment
Nov 18th, 2024
Headshots of speakers
AHA24
At the intersection of heart and brain
Nov 17th, 2024